Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SILVA: Adjuvant BEC2/BCG in Limited-Stage SCLC
NCT00006352Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Sep 1999
- Primary completion
- Oct 2002
- Modality
- Antibody Conjugates, scFv Fragments, Bispecific Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of blinatumomab in small cell lung cancer (SCLC), sponsored by European Organisation for Research and Treatment of Cancer. Started Sep 1999; status: completed.
02
Drugs
blinatumomab
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00006352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006352.